Syno Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 4
Professionals
  • Investments
  • 8
  • Portfolio
  • 3
  • Exits
  • 4
Exits

Syno Capital General Information

Description

Syno Capital is a venture capital firm which specializes in seed, early stage and later stage investments. It prefers to invest in the healthcare and information technology sectors. The firm was founded in 2015 and is based in New York, New York with additional office in Hong Kong, Hong Kong.

Contact Information

Website
www.synocapital.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 275 Madison Avenue
  • 39th Floor
  • New York, NY 10016
  • United States
+1 (646) 000-0000

Syno Capital Investments (8)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
PhaseBio 05-Sep-2018 Later Stage VC 0000 Drug Delivery Generating Revenue/Not Profitable
0000 000000000000 21-Mar-2018 00000 00000 00000 Pharmaceuticals Generating Revenue
0000000 0000000000 27-Jun-2017 00000 00000 0000 Monitoring Equipment Generating Revenue 000000 00000 00.0
0000000 0000000000 08-Feb-2017 00000 00000 00.000 Biotechnology Generating Revenue
00000 (00000 000 0 08-Aug-2016 00000 00000 0000 Elder and Disabled Care Generating Revenue
0000000 0000000000 16-Dec-2015 00000 00000 000.00 Monitoring Equipment Generating Revenue 000000 00000 00.0
LungLife AI 04-Jun-2015 Later Stage VC 000.00 Diagnostic Equipment Generating Revenue/Not Profitable 000000 00000 00.0
PhaseBio 12-Mar-2015 Later Stage VC 0000 Drug Delivery Generating Revenue/Not Profitable
To view Syno Capital’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Syno Capital Exits (4)

Company Name Exit Date Exit Type Exit Size
LungLife AI 08-Jul-2021 IPO 000.00
0000000 0000000000 14-May-2019 000 0000
TCR2 Therapeutics 14-Feb-2019 IPO 0000
PhaseBio 18-Oct-2018 IPO 0000
To view Syno Capital’s complete exits history, request access »

Syno Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Syno Capital Team (4)

Name Title Deals Funds Boards Office
Joseph Weilgus Co-Founder & Managing Director New York, NY
Justin Xiang Ph.D Co-Founder & Chief Investment Officer 0 0 New York, NY
Iris Yu Associate New York, NY
You’re viewing 3 of 4 team members. Get the full list »